Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

AMITKUMAR N MEHTA

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1003122573
CMS profile
1299712
Location
BIRMINGHAM, AL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$111,941.41

67 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
Incyte Corporation $34,205.51 20
ADC Therapeutics America, Inc. $20,404.66 9
AstraZeneca Pharmaceuticals LP $12,785.00 6
BeiGene USA, Inc. $12,607.65 7
E.R. Squibb & Sons, L.L.C. $11,543.93 5
Genentech USA, Inc. $10,011.49 7
Novartis Pharmaceuticals Corporation $5,333.12 5
Gilead Sciences, Inc. $4,110.00 1
Celgene Corporation $900.00 3
Kite Pharma, Inc. $40.05 4

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

67 matching records · $111,941.41 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 67 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 67.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
BeiGene USA, Inc. $962.0112/23/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261120844943 CMS
BeiGene USA, Inc. $5,200.0012/23/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261120844947 CMS
ADC Therapeutics America, Inc. $5,840.0012/18/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261121185442 CMS
AstraZeneca Pharmaceuticals LP $2,870.0012/18/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105222522 CMS
ADC Therapeutics America, Inc. $1,004.0012/14/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261121185440 CMS
ADC Therapeutics America, Inc. $123.6612/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261121185438 CMS
AstraZeneca Pharmaceuticals LP $60.0012/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105249388 CMS
Novartis Pharmaceuticals Corporation $119.6612/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261087149028 CMS
Novartis Pharmaceuticals Corporation $2,025.0012/06/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261087149030 CMS
Genentech USA, Inc. $2,280.0012/05/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261132975319 CMS
Genentech USA, Inc. $82.5912/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261132975321 CMS
ADC Therapeutics America, Inc. $5,840.0012/03/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261121185436 CMS
ADC Therapeutics America, Inc. $1,757.0011/27/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261121185434 CMS
E.R. Squibb & Sons, L.L.C. $4,447.0011/19/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101314417 CMS
Incyte Corporation $1,370.0011/12/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261141267013 CMS
Gilead Sciences, Inc. $4,110.0011/10/2024 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261186411647 CMS
AstraZeneca Pharmaceuticals LP $4,920.0011/06/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261104275053 CMS
Incyte Corporation $4,110.0011/05/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261141206663 CMS
Genentech USA, Inc. $43.2511/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261132975317 CMS
E.R. Squibb & Sons, L.L.C. $850.0510/30/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101314415 CMS
Incyte Corporation $980.9910/28/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261141249770 CMS
AstraZeneca Pharmaceuticals LP $525.0010/24/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105669549 CMS
E.R. Squibb & Sons, L.L.C. $2,964.0010/15/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101314405 CMS
E.R. Squibb & Sons, L.L.C. $3,176.0010/09/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101314399 CMS
ADC Therapeutics America, Inc. $3,650.0010/02/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261121185416 CMS
Genentech USA, Inc. $1,900.0009/26/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261132975315 CMS
Incyte Corporation $4,795.0009/26/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261141266869 CMS
E.R. Squibb & Sons, L.L.C. $106.8809/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101314401 CMS
Incyte Corporation $677.2509/11/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261141202887 CMS
Incyte Corporation $52.6009/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261141266867 CMS
Incyte Corporation $654.0009/11/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261141278956 CMS
Incyte Corporation $83.9909/04/2024 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/20261141272930 CMS
AstraZeneca Pharmaceuticals LP $4,110.0009/02/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105463625 CMS
BeiGene USA, Inc. $3,900.0008/28/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261120844932 CMS
BeiGene USA, Inc. $33.6408/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261120844936 CMS
BeiGene USA, Inc. $545.6608/28/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261120844939 CMS
Celgene Corporation $300.0008/05/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101107000 CMS
Genentech USA, Inc. $3,800.0007/08/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261132975323 CMS
Kite Pharma, Inc. $15.8006/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261128611793 CMS
ADC Therapeutics America, Inc. $730.0006/12/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261121185378 CMS
Incyte Corporation $1,370.0006/11/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261141196703 CMS
Incyte Corporation $4,110.0006/11/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261141254776 CMS
Incyte Corporation $654.0006/03/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261141197991 CMS
Novartis Pharmaceuticals Corporation $3,037.5005/31/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261087149020 CMS
Novartis Pharmaceuticals Corporation $90.0005/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261087149022 CMS
Novartis Pharmaceuticals Corporation $60.9605/31/2024 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261155561961 CMS
Celgene Corporation $300.0005/20/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101106998 CMS
Kite Pharma, Inc. $1.6205/19/2024 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261184375144 CMS
Kite Pharma, Inc. $4.3605/17/2024 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261184375146 CMS
Celgene Corporation $300.0005/08/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101107002 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $73,497.87 74
PY2020 $70,331.37 48
PY2021 $99,599.47 73
PY2022 $94,357.41 70
PY2023 $83,212.35 48
PY2024 $111,941.41 67
PY2025 $150,367.97 69

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
AMITKUMAR N MEHTA, NPI 1003122573. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1003122573.
APA 7
IndustryPayments. (2026). AMITKUMAR N MEHTA, NPI 1003122573 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1003122573
Bluebook
AMITKUMAR N MEHTA, NPI 1003122573, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1003122573.

Source: Centers for Medicare & Medicaid Services, Open Payments.